Please assess the completion status of the following clinical trial:

Trial Title: Single Low-dose Primaquine Efficacy and Safety.

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age from 1 to 10 years~* Weight ≥ 10 kg~* Body temperature ≥ 37.5°C or history of fever in the last 24 hours~* Microscopy confirmed P. falciparum mono-infection~* Parasitemia level of 2000 - 200000/µL~* Ability to swallow oral medication~* Ability and willingness to abide by the study protocol and the stipulated follow up visits~* Written proxy informed consent from a parent/guardian.~Exclusion Criteria:~* Evidence of severe malaria or danger signs~* Known allergy to trial medicines~* Reported antimalarial intake ≤ 2 weeks~* Hemoglobin \< 5 g/dL~* Blood transfusion within last 90 days~* Febrile condition other than malaria~* Known underlying chronic or severe disease

- Gender: ALL
- Minimum Age: 1 Year
- Maximum Age: 10 Years
- Healthy Volunteers: f

Study Arms:
- Single arm (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).